This Solicitation opportunity from Government of Canada was posted on August 4, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Request for information - E60PH-28MPIV - Pandemic Influenza Vaccine Readiness and Supply Strategy

Closed

WS5703210526International

Submission Closed08/14/2026, 07:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

Solicitation # SPE2DP-26-D-0001

The Defense Logistics Agency Troop Support is issuing a Request For Information to identify capable sources for the supply of Antidote Treatment Nerve Agent Auto-Injectors. These dual-chamber devices must be FDA licensed and capable of delivering 2.1 mg of atropine and 600 mg of pralidoxime chloride via intramuscular administration, adhering to MPID Number 6 specifications. Interested firms must provide details regarding their manufacturing location, annual capacity, FDA registration, pricing, and inventory levels. The agency is also accepting information from organizations with products currently under development, including the current stage of testing and trials. This RFI is intended for market research to inform future procurement strategies and does not constitute a formal solicitation or commitment to award a contract.

POSTED

DEADLINE

Lonza – Cryopreserved Primary Human Hepatocytes (spheroid-qualified)

Solicitation # 75N98026Q01231

The Department of Health and Human Services, through the National Institutes of Health and the National Institute of Environmental Health Sciences, intends to award a firm-fixed-price purchase order to Lonza for the procurement of 60 vials of spheroid-qualified cryopreserved primary human hepatocytes. The requirement consists of 30 vials from male donors and 30 vials from female donors to support Complement-ARIE research conducted by the National Center for Advancing Translational Sciences and the Division of Translational Toxicology. These specialized cells are essential for developing and evaluating three-dimensional microphysiological systems to model toxicity-induced human liver injury and fibrotic damage. This acquisition is conducted as a sole-source procurement under FAR Part 12 simplified acquisition procedures because Lonza is the only identified source capable of providing the specific combination of spheroid-qualified preparations, donor diversity, and re-qualified cell lots necessary to maintain consistency and reproducibility in the established research methodology. The cells must be delivered in liquid nitrogen storage to the NIEHS facility in Research Triangle Park, North Carolina, by September 25, 2026. Final acceptance of the materials is contingent upon the successful formation of rounded spheroids within the NIEHS laboratory. The applicable NAICS code for this procurement is 325414, and the PSC is 6640.

National Institutes Of Health Olao

POSTED

DEADLINE

2027 Southern Hemisphere Influenza Vaccine

Solicitation # SPE2DP26R0002

The Defense Logistics Agency Troop Support is seeking a contractor to supply approximately 30,000 doses of Southern Hemisphere Influenza Vaccine for the 2027-2028 flu season. The vaccines must be FDA-approved, ACIP-recommended, and provided as pre-measured 0.5 ML doses in pre-filled syringes for intramuscular administration in individuals aged 6 months and older. The specific vaccine formula will be determined by the FDA Vaccines and Related Biological Products Advisory Committee. This is an indefinite quantity contract with a guaranteed minimum of 75 percent and a maximum of 150 percent of the annual estimate. All supplies must be delivered to the Defense Depot in New Cumberland, Pennsylvania, with a preferred completion date of March 12, 2027. Interested parties can find the solicitation on DIBBS and SAM.gov, with the primary point of contact being Rosbert Jones.

POSTED

DEADLINE

GLOBULIN, RHO (D) IMMUN

Solicitation # SPE2DP-26-T-5063

Solicitation SPE2DP-26-T-5063 is a fixed-price request for quotations issued by the Defense Logistics Agency Troop Support Medical Supply Chain Pharm FSA for the acquisition of one unit of Globulin Rho (D) Immune. The required product is an FDA-regulated medical drug, specified as USP 300 MCG adult dose, provided in a disposable 1ML syringe with safety for intramuscular injection. The item must be stored between 2 and 8 degrees Celsius and must not be frozen. A current Material Safety Data Sheet is required for this item. The delivery is set for September 16, 2026, with a shipping destination of the USS Jeremiah Denton DDG129 at the COSAL Warehouse in Gulfport, Mississippi. Inspection and acceptance will occur at the destination. Packaging must adhere to MIL-STD-129 for marking and RP001 for palletization, with specific requirements for hazardous materials under TQ requirement IP025 and 49 CFR if applicable. Invoicing and payment requests must be processed electronically through the Wide Area WorkFlow system. The solicitation incorporates various FAR and DFARS clauses, including those regarding the Buy American Act, safeguarding covered defense information, and combating trafficking in persons. Quotes must be submitted via the DIBBS system by September 21, 2026.

Defense Logistics Agency

POSTED

DEADLINE

ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV

Solicitation # WS5872093541

Public Services and Procurement Canada, acting on behalf of the Public Health Agency of Canada, has issued an Advanced Contract Award Notice for the procurement of Vaccinia Immunoglobulin intravenous (human), known as VIGIV. This medical product is required to protect against complications arising from vaccinations with live-replicating smallpox vaccines containing the vaccinia virus. The government intends to negotiate a contract with Emergent BioSolutions Canada Inc, provided no other qualified suppliers express interest. The solicitation, identified by number WS5872093541, was posted on September 10, 2026, with a response deadline of September 30, 2026. Other potential suppliers may submit a statement of capabilities by this date to challenge the pre-identified award. The contract is managed by the Department of Public Works and Government Services for performance within Canada.

Department of Public Works and Government Services

POSTED

DEADLINE

Medical Diagnostic Test Kit SupplyThe Defense Logistics Agency under the Department of Defense has issued a subcontract for the supply of 100 E. coli detection test kits. These diagnostic kits must strictly adhere to FDA regulations, specific shelf-life requirements, and Department of Defense medical packaging standards to ensure quality and viability. Classified under NAICS code 325414, this procurement focuses on the delivery of specialized medical diagnostic tools. The contract was posted on August 11, 2026, and is managed through the DLA's acquisition systems to support military medical readiness.

Defense Logistics Agency

POSTED

DEADLINE

Medical Supply Procurement – Petrolatum GauzeThis subcontract with the Defense Logistics Agency under the Department of Defense involves the manufacture or supply of 27 units of petrolatum gauze, identified by NSN 6510-01-112-6414. The procurement falls under NAICS code 325414 and requires all units to meet strict military medical standards. Key delivery requirements include a minimum shelf life of 36 months, with a mandate that the time elapsed from manufacture to delivery does not exceed five months. The contract was posted on August 10, 2026.

Defense Logistics Agency

POSTED

DEADLINE

Typhoid Vi Polysaccharide Vaccine SupplyThis subcontract through the Defense Logistics Agency under the Department of Defense involves the supply of 1,000 units of FDA-compliant, preserved Typhoid Vi Polysaccharide Vaccine. The procurement is categorized under NAICS code 325414 and is designated for delivery to a U.S. Navy vessel. The agreement is established under FOB Destination terms, ensuring the delivery of the medical supplies to the specified naval location. The contract was posted on August 10, 2026, and is managed via the DIBBS system.

Defense Logistics Agency

POSTED

DEADLINE

Supply and Delivery of Typhoid VI Polysaccharide Vaccine (NSN 6505015334962)This subcontract with the Defense Logistics Agency involves the procurement, packaging, and delivery of 1,000 units of preservative-free Typhoid VI Polysaccharide Vaccine. The product must comply with NDC 49281-0790-51 and NSN 6505015334962. The vaccines are to be delivered to the USS Theodore Roosevelt (CVN 71) at FPO AP 96632 by August 10, 2026. Shipping must be handled via FOB Destination using fast and traceable methods to ensure secure arrival.

Defense Logistics Agency

POSTED

DEADLINE

MMR Vaccine Supply and Delivery

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Product Supply – Aluminum Hydroxide Gel

Defense Logistics Agency

POSTED

DEADLINE

Measles, Mumps, and Rubella (MMR) Vaccine Supply and DeliveryThe contract entails the supply and delivery of three units of Measles, Mumps, and Rubella vaccine to a U.S. Navy vessel at a forward operating base destination, with strict requirements for traceable express shipping and full compliance with established medical handling standards. The contractor is responsible for ensuring the vaccines remain viable throughout transit by adhering to temperature control, packaging, and documentation protocols mandated for biological materials. This is a subcontract under the Department of Defense, managed by the Defense Logistics Agency, with a NAICS code of 325414 indicating pharmaceutical preparation manufacturing. The delivery must be completed in accordance with military logistics guidelines, and all shipping records must maintain a verifiable chain of custody from origin to final receipt aboard the vessel. The contract was posted on August 9, 2026, and the place of performance is tied to a military operational location, though specific geographic details are not provided. The award reference number SPE2DX25D8022 and delivery identifier SPE2D926F8119 are linked to the official DLA procurement system, underscoring the mission-critical nature of timely and secure delivery. While the solicitation number is not listed, the subcontract structure suggests coordination with a prime contractor to fulfill the DOD’s medical readiness requirements. All activities must comply with federal regulations governing vaccine distribution and military supply chain integrity.

Defense Logistics Agency

POSTED

about 1 month ago

DEADLINE

N/A

AI Contract Overview

Canada is seeking input from vaccine suppliers to inform its medium- and long-term strategy for ensuring readiness and supply of Pandemic Influenza Vaccine, with a target capacity to produce up to 110 million doses of a monovalent vaccine. This request for information aims to identify potential bidders capable of meeting the government’s needs for rapid, scalable vaccine production in the event of a pandemic, and to better understand industry capabilities, timelines, and conditions for fulfilling future contract opportunities. The initiative is led by the Department of Public Works and Government Services on behalf of the Government of Canada, with responses due by August 7, 2026, and all performance expected to take place within Canada. The NAICS code 325414 indicates the focus is on pharmaceutical and medicine manufacturing, and the sole point of contact for inquiries is Yessica Karnali Wijayaputri of SPAC/PSPC, reachable via email.

General Info

Canada seeks supplier capabilities to ensure 110 million pandemic flu vaccine doses by 2026.

Agency

Government of Canada → Department of Public Works and Government ServicesView Agency

NAICS

325414 - Biological Product (except Diagnostic) ManufacturingView NAICS

Place of Performance

Canada, CAN

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

2 updates

PhaseClosed

PostedJun 22

Solicitation

Notice updatedJun 22

Response deadline time changed from 2:00 PM UTC to 7:00 PM UTC on Aug 7, 2026. The point of contact changed.

Deadline changedAug 4

Response deadline changed from Aug 7, 2026 to Aug 14, 2026.

Response DeadlineAug 14

Deadline has passed

Submission Closed

08/14/2026, 07:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyGovernment of Canada → Department of Public Works and Government Services

Contacts1 person available

OfficeN/A

Organization / Agency

Government of Canada → Department of Public Works and Government Services

View Agency Profile

Office AddressN/A

Contacts

Wijaya Putri Yessica Karnali (SPAC/PSPC) (elle-la / she-herContracting Authority

contact@example.gov

Full Description

Canada has a requirement for Pandemic Influenza Vaccine (PIV) readiness and supply to secure sufficient production capacity for up to 110 million doses of a monovalent PIV. To support the development of these requirements, Canada is seeking input from suppliers with a potential interest in bidding on future PIV Readiness and Supply contract(s), to address Canada’s medium- and/or long-term PIV readiness and supply needs.